However, at advanced stages, persistent NRF2 hyperactivation creates an environment that may favour the survival of tumour cells by protecting them from excessive oxidative stress, chemotherapeutic agents, or radiotherapy [10,13,14]. The gene discussed is NFE2L2; the disease is neoplasm.